Ledger.Open graph →
SEC Form D · filed March 18, 2015

Banyan Biomarkers, Inc

Offering
$5.0M
Sold
$1.8M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
San Diego, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (31)

Darin Glatt · Portland, ORExecMichael Flaherty · Los Angeles, CADirectorJames B. Kelly · Huntsville, ALExec · DirectorXiaoqing Xu · Central, Hong KongDirectorHeiner Dreismann · Seattle, WAExecScott Winters · San Rafael, CAExecRonald Hayes, Ph.D · San Diego, CAExec · DirectorIsaac K. Blech · Cambridge, MAExec · DirectorAllan Stephan · Seattle, WADirectorWilliam Roper, Jr · San Diego, CADirectorWill K. Young · Las Vegas, NVDirectorDavid Flagg · Alachua, FLDirectorDavid M. Klubert · Huntsville, ALDirectorJulie Pashkowsky · San Diego, CAExecNancy Denslow, Ph.D · San Diego, CADirectorTyler Mckinley · Portland, ORDirectorDavid Flagg · Alachua, FLDirectorWilliam Nelson, Jr · San Rafael, CADirectorJackson Streeter, M.D · San Diego, CAExec · DirectorTony Grover · San Diego, CAExecHenry Nordhoff · San Diego, CADirectorDominik M. Aronsky · Huntsville, ALExecSteven Richieri · San Diego, CAExecPeter K. Farrell, Ph.D · Cambridge, MAExec · DirectorMarcus K. Semones, Ph.D · Cambridge, MAExecPeter B. Finn, Esq · Boston, MAExecHarold Kawaguchi · Seattle, WAExec · DirectorAndrew Von Eschenbach, M.D · San Diego, CADirectorStanford Warshawsky · San Diego, CADirectorBen Malka · San Rafael, CADirectorStephen Rose · Seattle, WADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗